Clinical Trial Update: CD19-CAR-T2 Cells for CD19 Positive B Cell Malignancies [Phase 2]

View source ↗

Summary

This update announces the completion of a Phase 2 trial evaluating CD19-CAR-T2 cells for CD19-positive B-cell malignancies, including B-cell leukemia and B-cell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Leukemia
• B-cell Lymphoma

Drugs mentioned

• CD19-CAR-T2 Cells (CD19-targeted CAR-T cells)

Snippet

Sponsor: Nanfang Hospital, Southern Medical University | Conditions: B Cell Leukemia, B Cell Lymphoma | Phase 2 | Status: COMPLETED